Viewing Study NCT01873534


Ignite Creation Date: 2025-12-25 @ 2:29 AM
Ignite Modification Date: 2026-03-04 @ 8:46 PM
Study NCT ID: NCT01873534
Status: TERMINATED
Last Update Posted: 2015-08-11
First Post: 2013-06-05
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 2A Trial of FMX-8 Treatment for Anemia in Patients With ESRD on Hemodialysis HD
Sponsor: FerruMax Pharmaceuticals, Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: FX-C-402
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View